Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
Inflow
Outflow
Net flow
Funds Holding
3,298
Funds Holding Change
+4
Funds Holding Growth
+0.1%
Value
$1.14T
Holding in Top 10
1,212
Top 10 Change
+146
Top 10 Growth
+14%
Value Growth
+12%
New
85
Increased
1,404
Reduced
1,584
Closed
53
Capital Inflow
$34.6B
Capital Outflow
$34.4B
Net Capital Flow
+$184M
Capital Flow Change
-$4.95B
Calls
$11B
Puts
$12.5B
Net Calls
-$1.59B
Put/Call Ratio
1.14